TP53 and non-small cell lung carcinoma: The novelty of our study lies in the first finding of great prognostic role of EAp53 classification system in advanced NSCLC which might presently be the most powerful prognostication tool for classifying patients with TP53 mutations whether they received targeted therapies or chemotherapies, as well as elucidating the molecular features related to this system.